2017年比利时某大学医院急性中毒成人住院费用分析及与全国数据对标
该研究分析了根特大学医院(GUH)2017年收治的1175例14岁及以上急性中毒患者的病历与账单,计算直接费用并用广义线性模型(gamma loglink)分析费用相关因素;同时将GUH数据与2016年比利时全国医院数据(All Patient Refined Diagnosis Related Groups 812和816)对标。结果显示每例中位直接费用512美元,门诊199美元、急诊观察室1575美元、住院3398美元、ICU 4859美元;费用相关因素包括性别、严重程度、住院类型、故意性以及乙醇、对乙酰氨基酚、抗抑郁药或苯丙胺的涉及。GUH药物中毒每例中位住院费用比全国数据高70.5%,非药物中毒比2016年全国中位数高54.5%。作者认为住院类型对费用影响大,主要因住院时长,住宿占费用很大比例,并强调医院应与(国际)国家数据对标以持续改进费用管理。
要点
- 1175例急性中毒患者总直接费用为1,830,870美元,每例中位直接费用512美元。
- 按住院类型分层的中位直接费用:门诊199美元、急诊观察室1575美元、住院3398美元、ICU 4859美元。
- 费用相关因素包括性别、严重程度、住院类型、故意性以及乙醇、对乙酰氨基酚、抗抑郁药或苯丙胺的涉及。
- GUH药物中毒每例中位住院费用比全国数据高70.5%,非药物中毒比2016年全国中位数高54.5%。
- 作者认为住院类型对费用影响大,主要因住院时长,住宿占费用很大比例,医院应与(国际)国家数据对标以评估自身费用管理。
适用人群与场景
- 2017年就诊于根特大学医院(GUH)急诊科、14岁及以上、因中毒相关的全部患者记录与账单。
研究设计与关键结果
- 研究类型为单中心费用分析,纳入2017年GUH急诊科14岁及以上中毒相关患者1175例,总直接费用1,830,870美元,每例中位直接费用512美元。
- 按住院类型的中位直接费用:门诊199美元、急诊观察室1575美元、住院3398美元、ICU 4859美元。
- 广义线性模型(gamma loglink)显示与费用相关的因素为性别、严重程度、住院类型、故意性以及乙醇、对乙酰氨基酚、抗抑郁药或苯丙胺的涉及。
- GUH药物中毒每例中位住院费用比全国住院数据高70.5%,非药物中毒每例中位费用比2016年全国中位数高54.5%。
证据类型、等级与局限
- 证据类型:单中心费用分析,使用病历与账单数据,并与2016年全国医院数据(All Patient Refined Diagnosis Related Groups 812和816)对标。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为住院类型对费用影响大,主要因住院时长,住宿占费用很大比例。
- 作者认为医院应与(国际)国家数据对标,以在持续改进的背景下评估自身费用管理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Objective: Aims were to (1) analyse the direct cost charged by a university hospital to the government and the patient in case of an admission for acute poisoning, (2) identify the factors associated with the cost, and (3) compare the cost in the hospital studied with national data from the government.Methods: Patient records and invoices of all poisoning-related episodes of patients 14 years or older admitted to the Emergency Department (ED) of Ghent University Hospital (GUH) in 2017 were analysed. A generalised linear model with gamma loglink was applied to assess the variables associated with the cost. Our GUH data collected in 2017 were compared with national data 2016 for all Belgian hospitals on the one hand, and for the subgroup of GUH 2016 data on the other hand. To do this, we used data provided by the Technical Unit of the Federal Public Service Health, containing All Patient Refined Diagnosis Related Groups 812 (poisoning by medicinal agents) and 816 (toxic effects by non-medicinal substances).Results: The total direct cost for the treatment of 1,175 poisoned patients amounted to $1,830,870. Median direct cost per patient was $512 per episode, with $199 for ambulatory patients, $1,575 for patients admitted to the ED-observation-unit, $3,398 for hospitalised patients and $4,859 for patients treated in the intensive care unit. Factors associated with the cost were gender, degree of severity, type of hospitalisation, intentionality, and involvement of ethanol, paracetamol, antidepressants or amphetamines. Median hospitalisation cost per admission in GUH for medicinal agents was 70.5% higher than the cost reported in national hospitalisation data. Median cost per admission in case of non-medicinal agents was 54.5% higher than the national median 2016.Conclusion: The type of hospitalisation has a high impact on the cost, a.o. primarily due to the length of hospital stay, with accommodation accounting for a large proportion of the costs. It is important to benchmark individual hospital data with (inter)national data to evaluate its own cost management in the context of continuous improvement.
参考来源
- Descamps AM, De Paepe P, Buylaert W, et al. Adults with acute poisoning admitted to a university hospital in Belgium in 2017: cost analysis benchmarked with national data. Clin Toxicol (Phila). 2019. PMID: 31423847. doi:10.1080/15563650.2019.1651856
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。